Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects.
Saved in:
| Title: | Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects. |
|---|---|
| Authors: | Modi NB; Protagonist Therapeutics, Inc., Newark, CA, USA., Dinh P; Protagonist Therapeutics, Inc., Newark, CA, USA., Ajari I; Protagonist Therapeutics, Inc., Newark, CA, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2025 Apr; Vol. 14 (4), pp. 311-323. Date of Electronic Publication: 2025 Jan 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
